Bannerbild German Brest Group - Studien

PATINA (GBG 94)

PATINA

A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy after Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive Metastatic Breast Cancer

EudraCT#: 2017-000419-17
ClinicalTrials.gov Identifier: NCT02947685
Protocol Number: AFT-38
US Sponsor Name: Alliance Foundation Trials (AFT), LLC

 
 

News

Status: recruiting limit reached

Last Patient Last Visit expected: Apr 2026

Trial Design

Contact

ptngbgd
Fax: +496102 / 7480-440

GBG Forschungs GmbH
Dornhofstr. 10 | 63263 Neu-Isenburg | Fax +49 6102 7480-440

+49 6102 7480-0 | nfGBGd